PENGUIN.BIO
Live / Applied — First extension granted (statement of use) (as of 04 Feb 2026)
What this means for you
Not registered yet, but its 12 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98899705
- Mark type
- Stylized text
- Filed
- 12 Dec 2024
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of metabolic diseases
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- PENGUIN BIO CORP., NEW YORK, NY, US
- PENGUIN BIO CORP., NEW YORK, NY, US
- Ghrelco, Inc., New York, NY, US
Prosecution history
- 04 Feb 2026 — SOU EXTENSION 1 GRANTED
- 04 Feb 2026 — SOU EXTENSION 1 FILED
- 04 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2025 — ASSIGNED TO EXAMINER
- 21 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Dec 2024 — NEW APPLICATION ENTERED